|
 |
| |
Staff Bio
Don C. Des Jarlais, Ph.D.
Position Title - Deputy Director, Infectious Diseases and Interdisciplinary Research Methods Core
- Director of Research, Baron Edmond de Rothschild, Chemical Dependency Institute, Beth Israel Medical Center
- Principal Investigator
- Senior Research Fellow, NDRI
Affiliation Beth Israel Medical Center
Education Ph.D., Social Psychology, University of Michigan
Current Projects - Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review
- Principal Investigator, HIV Transmission among Injection Drug Users in Tallinn, Estonia
- Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia
- Principal Investigator, Risk Factors for HIV/AIDS in Drug Users
- WHO Survey Coordinating Center, Drug Injecting Study-Phase 2
Awards and Memberships - New York City Mayor's Commission on AIDS
- Chair, Prevention Science Working Group, National Institutes of Health, Office of AIDS Research
- Consultant on AIDS: Institute of Medicine - National Academy of Sciences, National Institute on Drug Abuse, Centers for Disease Control and Prevention, World Health Organization
- National Institute on Drug Abuse (NIDA) External Research Advisory Board, 1996
- Vice Chairman, Committee on AIDS Research and the Behavioral, Social, and Statistical Sciences, National Research Council, National Academy of Sciences, 1991-1994
- National Commission Acquired Immunodeficiency Syndrome (AIDS), 1989-1993
Academic Appointments - Visiting Professor, Psychology, Columbia University
- Guest Investigator, Rockefeller University
- Professor, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY
|
|
Coffin, L. S., Newberry, A., Hagan, H., Cleland, C. M., Des Jarlais, D. C., & Perlman, D. C. (2010). Syphilis in drug users in low and middle income countries. International Journal of Drug Policy, 21 (1), 20-27.
|
|
Des Jarlais, D. C. (2010). Learning from HIV epidemics among injecting drug users. International Journal of Drug Policy, 21 (2), 97-99.
|
|
Des Jarlais, D. C., Arasteh, K., & Gwadz, M. (2010). Increasing HIV prevention and care for injecting drug users. Lancet, 375 (9719), 961-963.
|
|
Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D. C., Torian, L. V., Beatrice, S., Semaan, S., & Friedman, S. R. (2010). HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: The importance of transmission behaviors. Drug and Alcohol Dependence, 109 (1-3), 154-160.
|
|
Des Jarlais, D. C., Arasteh, K., McKnight, C., Ringer, M., & Friedman, S. R. (2010). Syringe exchange, injecting and intranasal drug use. Addiction, 105 (1), 155-158.
|
|
Masson, C. L., Sorensen, J. L., Grossman, N., Sporer, K. A., Des Jarlais, D. C., & Perlman, D. C. (2010). Organizational issues in the implementation of a hospital-based syringe exchange program. Substance Use and Misuse, 45 (6), 901-915.
|
|
Meader, N., Li, R., Des Jarlais, D. C., & Pilling, S. (2010). Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database of Systematic Reviews (1), CD007192.
|
|
Quaglio, G., Pattaro, C., Gerra, G., Mezzelani, P., Montanari, L., Des Jarlais, D. C., & Lugoboni, F. (2010). Buprenorphine in maintenance treatment: Experience among Italian physicians in drug addiction centers. American Journal on Addictions, 19 (3), 222-230.
|
|
Semaan, S., Heckathorn, D. D., Des Jarlais, D. C., & Garfein, R. S. (2010). Ethical considerations in surveys employing respondent-driven sampling. American Journal of Public Health, 100 (4), 582-583.
|
|
Uuskula, A., Johnston, L. G., Raag, M., Trummal, A., Talu, A., & Des Jarlais, D. C. (2010). Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. Journal of Urban Health, 87 (2), 304-317.
|
|
Arasteh, K., & Des Jarlais, D. C. (2009). At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care and STDs, 23 (8), 657-661.
|
|
Arasteh, K., & Des Jarlais, D. C. (2009). HIV testing and treatment among at-risk drinking injection drug users. Journal of the International Association of Physicians in AIDS Care, 8 (3), 196-201.
|
|
Booth, R. E., Des Jarlais, D. C., & Friedman, S. R. (2009). Reflections on 25 years of HIV and AIDS research among drug abusers. Journal of Drug Issues, 39 (1), 209-222.
|
|
Broadhead, R. S., Hammett, T. M., Kling, R., Doan, N., Liu, W., Chen, Y., Hoang, N. Q., Kieu, T. B., Hoang, V. T., Borch, C., Gauchat, G., & Des Jarlais, D. C. (2009). Peer-driven interventions in Vietnam and China to prevent HIV: A pilot study targeting injection drug users. Journal of Drug Issues, 39 (4), 829-850.
|
|
Cooper, H. L., Bossak, B. H., Tempalski, B., Friedman, S. R., & Des Jarlais, D. C. (2009). Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: Relationship to local racial/ethnic composition and need. Journal of Urban Health, 86 (6), 929-945.
|
|
Cooper, H. L., Bossak, B., Tempalski, B., Des Jarlais, D. C., & Friedman, S. R. (2009). Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy, 20 (3), 217-226.
|
|
Des Jarlais, D. (2009). National and international aspects of doing harm reduction better. Addiction, 109 (9), 1452-1453.
|
|
Des Jarlais, D. C., & Hubbard, R. L. (2009). Drug abuse. In R. Detels, R. Beaglehole, M. A. Lansang, & M. Gulliford (Eds.), Oxford textbook of public health: The scope of public health (5th ed., 1303-1321). New York: Oxford University Press.
|
|
Des Jarlais, D. C., & Semaan, S. (2009). HIV prevention and psychoactive drug use: A research agenda. Journal of Epidemiology and Community Health, 63 (3), 191-196.
|
|
Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D. C., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99 (Suppl 2), S445-S451.
|
|
Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Friedman, S. R. (2009). Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence, 101 (1-2), 88-91.
|
|
Des Jarlais, D. C., Arasteh, K., Semaan, S., & Wood, E. (2009). HIV among injecting drug users: Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. Current Opinion in HIV and AIDS, 4 (4), 308-313.
|
|
Des Jarlais, D. C., McKnight, C., Goldblatt, C., & Purchase, D. (2009). Doing harm reduction better: Syringe exchange in the United States. Addiction, 104 (9), 1441-1446.
|
|
Edlin, B. R., Shu, M. A., Winkelstein, E., Des Jarlais, D. C., Busch, M. P., Rehermann, B., O'Brien, T. R., Talal, A. H., Tobler, L. H., Zeremski, M., & Beeder, A. B. (2009). More rare birds, and the occasional swan. Gastroenterology, 136 (7), 2412-2414.
|
|
Holtzman, D., Barry, V., Ouellet, L. J., Des Jarlais, D. C., Vlahov, D., Golub, E. T., Hudson, S. M., & Garfein, R. S. (2009). The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Preventive Medicine, 49 (1), 68-73.
|
|
Page(s)
|
| 1 2 3 4 5 6 7 8 9 10 ... |
|
| |
|
|
|
 |